U.S. FDA authorizes Pfizer's COVID-19 vaccine for emergency use in kids 5 to 11
CBC
The U.S. Food and Drug Administration on Friday paved the way for children ages five to 11 to get Pfizer-BioNTech's COVID-19 vaccine.
The FDA cleared kid-size doses — just a third of the amount given to teens and adults — for emergency use, and up to 28 million more American children could be eligible for vaccinations as early as next week.
One more regulatory hurdle remains: On Tuesday, advisers to the Centers for Disease Control and Prevention will make more detailed recommendations on which youngsters should get vaccinated, with a final decision by the agency's director expected shortly afterwards.
More to come
More Related News